Health Care/Hospital

Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics

* TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data demonstrates its accuracy in detecting rare genetic diseases * 40% increase in output to 35 billion reads, up to Q70 quality scores, improved turnaround time, and staggered sta...

2026-02-27 08:00 2922

Optellum Secures TGA Approval to Expand AI-Enabled Lung Nodule Solution To Australia

OXFORD, England, Feb. 27, 2026 /PRNewswire/ -- Optellum, the leading AI-enabled solution for earlier lung cancer detection, is thrilled to announce that it has received Therapeutic Goods Administration (TGA) class IIb approval in Australia for the Virtual Nodule Clinic (VNC) platform to support e...

2026-02-27 05:01 2543

Neurizon Initiates Dosing of NUZ-001 in HEALEY ALS Platform Trial

Highlights: * First participant enrolled and dosed with NUZ-001 in Regimen I of the HEALEY ALS Platform Trial evaluating NUZ-001 for the treatment of ALS * Approximately 160 participants with ALS will be enrolled in a 36-week randomised,double-blind, placebo-controlled adaptive Phase 2/3 clin...

2026-02-27 04:34 2705

ArisGlobal Launches NavaX Translation to Eliminate Manual Translation in Global Pharmacovigilance

Strategic partnership with TransPerfect Life Sciences embeds certified, pharma-grade translation directly into LifeSphere Safety workflows BOSTON, Feb. 26, 2026 /PRNewswire/ -- ArisGlobal

2026-02-26 22:12 3024

SK bioscience, IDT Biologika and Vaxxas Selected for Next-Generation Influenza Vaccine development Financed by the European Union

* SK–IDT–Vaxxas consortium establishes strategic entry point for high-density microarray patch (HD-MAP) vaccines inEurope to improve vaccine performance and access. * Parallel development of high-immunogenicity HD-MAP vaccines for seasonal and pandemic influenza threats. INCHEON, South Korea,...

2026-02-26 21:00 3222

CJ BIO Publishes Clinical Study on BiomeNrich™ POST SZ075, a Postbiotic Ingredient Demonstrating Skin Improvement Benefits

SEOUL, South Korea, Feb. 26, 2026 /PRNewswire/ -- CJ BIO announced the publication of clinical research findings on its postbiotic ingredient, BiomeNrich™ POST SZ075, in an international peer-reviewed journal. The study strengthens the scientific foundation of the ingredient and supports its pos...

2026-02-26 18:40 2679

HealthTech Partners Global Expands Clinical Education Division and Appoints Strategic Advisor Rusty Page Under Leadership of Former DIH Commercial VP Allison Krumpe

RICHMOND, Va., Feb. 26, 2026 /PRNewswire/ -- HealthTech Partners Global today announced a major expansion of its international clinical education division, alongside the appointment of strategic advisor Rusty Page, whose expertise in operations, quality, and IT will strengthen the company's globa...

2026-02-26 18:05 2624

Health Awareness Week Underscores the Importance of Respiratory Health

NEW YORK, Feb. 26, 2026 /PRNewswire/ -- As Health Awareness Week brings focus to preventive care and chronic condition management,VARON is highlighting the vital role respiratory health plays in overall well-being. Through its"Your Health, Our C...

2026-02-26 16:42 2407

genOway: Revolutionizing the Prediction of Antibody Therapies in Humans with Unique Mouse Model

LYON, France, Feb. 26, 2026 /PRNewswire/ -- Antibody therapies are changing the treatment of cancer, inflammatory diseases and infections. However, many promising drug candidates fail in clinical trials. A study in Science Immunology shows that genOway's genO-hFcγR mouse model enables more accura...

2026-02-26 16:15 3024

BC30™ Approved for "Live Culture" Claim in Indonesia, Opening Opportunities in F&B Innovation

JAKARTA, Indonesia, Feb. 26, 2026 /PRNewswire/ -- Kerry's BC30™

2026-02-26 14:02 2586

Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics

At AGBT, researchers reveal new findings from studies leveraging Illumina's multiomics solutions  SAN DIEGO, Feb. 26, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced new customer breakthroughs in oncology powered by Illumina's spatial transcriptomics, 5-base sequencing, and proteomi...

2026-02-26 13:54 3222

/C O R R E C T I O N -- World Gym/

In the news release, World Gym Corporation Will Participate in Fireside Chat with IPO Edge on February 27, 2026, issued 25-Feb-2026 by World Gym over PR Newswire, we are advised by the company that the release should include the register link. The complete, corrected release follows: World Gym C...

2026-02-26 00:38 5302

Illumina launches TruPath Genome, setting a new standard in genomic insight

* TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow * Data presented at AGBT demonstrates TruPath Genome's accuracy in detecting rare genetic disease * Broad Clinical Labs is among first to adopt product, which was previously known as "constellation...

2026-02-25 23:06 2756

Canadian hospital now ranked #2 in the world

UHN achieves highest-ever position in Newsweek's World's Best Hospitals ranking TORONTO, Feb. 25, 2026 /PRNewswire/ -- University Health Network's Toronto General Hospital has rankedsecond in the world in Newsweek magazine's World's Best Hospitals 2026, marking the highest position ever achieved ...

2026-02-25 22:23 2156

Discovery linking gut bacteria to cancer treatment wins the Bial Award in Biomedicine and earns €350,000 prize

A study published in Science reveals that a healthy gut microbiota can enhance the efficacy of immunotherapy used to treat cancer, while antibiotics may impair its effect by reducing intestinal microbiota diversity. PORTO, Portugal, Feb. 25, 2026 /PRNewswire/ -- An international consortium of 48...

2026-02-25 22:00 3632

Polaroid Therapeutics (PTx) Receives CE Mark for POLTX_Fiber™: the first application of APT™ to launch a new standard in wound care

Introducing Antimicrobial Polymer Technology (APT™) in POLTX_Fiber™, a Class IIb advanced wound care dressing that does not contribute to antimicrobial resistance: offering improved wound management through the prevention of bacterial colonization within the dressing. ZURICH, Feb. 25, 2026 /PRNe...

2026-02-25 16:30 3314

Smartee Delivers Master Class on "Mandibular Repositioning" in Sydney at Invitation of EODO

SYDNEY, Feb. 14, 2026 /PRNewswire/ -- At the invitation of the Excellence in Orthodontics and Dentofacial Orthopedics (EODO), Smartee Denti-Technology held a specialized Master Class at the Dental Education Centre (DEC) in Sydney on February 7.  This session attracted 80 dental professionals, wit...

2026-02-25 13:41 2663

SteinCares and Shilpa Biologicals Strike into Licensing Agreement to Expand Access to Biosimilars Across Latin America

* New partnership combines Shilpa Biologicals' development and manufacturing capabilities with SteinCares' regional commercialization platform * Collaboration aims to expand patient access to cost-effective treatments and reinforces SteinCares' leadership in biosimilars across Latin America ...

2026-02-25 09:00 3512

Antengene Announces Clinical Collaboration with Junshi Biosciences to Explore the Synergistic Potential of ATG-037 (Oral CD73 Inhibitor) In Combination with JS207 (PD-1/VEGF BsAb)

SHANGHAI and HONG KONG, Feb. 25, 2026 /PRNewswire/ -- Antengene Corporation Limited  ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune d...

2026-02-25 08:30 3345

Direct Genome-Scale Mapping of Endonuclease Activity of the Human LINE-1 ORF2p Endonuclease

Nabsys and the Research Lab of Dr. Martin Taylor, Brown University, Present Data Using the OhmX™ Platform at AGBT 2026 PROVIDENCE, R.I., Feb. 25, 2026 /PRNewswire/ -- Nabsys 2.0, LLC (Nabsys), a pioneer in electronic genome mapping (EGM) technology, today announced new findings presented at the ...

2026-02-25 02:30 2957
123456 ... 855